Evidence map›Paper›PMID 38678293›Full record

ArticleAIDS research and therapy2024

Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report.

Percina Machava, Winete Joaquim, Joseph Borrell, Shannon Richardson, Uneisse Cassia, Muhammad Sidat, Alice Maieca, Cláudia Massitela, Yara Quelhas, Cafrina Mucuila and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in AIDS research and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Percina Machava *Hospital Central de Maputo, Maputo, Mozambique.
Winete Joaquim *Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique. jwinete@gmail.com.
Joseph BorrellUniversity of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Shannon RichardsonUniversity of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Uneisse CassiaUniversidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
Muhammad SidatUniversidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
Alice MaiecaUniversidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
Cláudia MassitelaUniversidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
Yara QuelhasHospital Central de Maputo, Maputo, Mozambique.
Cafrina MucuilaHospital Central de Maputo, Maputo, Mozambique.
Beatriz EliasHospital Central de Maputo, Maputo, Mozambique.
Massada da RochaHospital Central de Maputo, Maputo, Mozambique.
H Simon SchaafDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
W Chris BuckHospital Central de Maputo, Maputo, Mozambique.
Eduardo Mondlane University · MZMaputo Central Hospital · MZUniversity of California, Los Angeles · USDesmond Tutu HIV Foundation · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacillus Calmette-Guérin (BCG) reactions are the most common cause of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive infants who initiate antiretroviral therapy (ART). There is limited evidence regarding the incidence of BCG-IRIS; however, reports from outpatient cohorts have estimated that 6-9% of infants who initiated ART developed some form of BCG-IRIS within the first 6 months. Various treatment approaches for infants with BCG-IRIS have been reported, but there is currently no widely accepted standard-of-care. CASE PRESENTATION: A 5-month-old male HIV-exposed infant BCG vaccinated at birth was admitted for refractory oral candidiasis, moderate anemia, and moderate acute malnutrition. He had a HIV DNA-PCR collected at one month of age, but the family never received the results. He was diagnosed with HIV during hospitalization with a point-of-care nucleic acid test and had severe immune suppression with a CD4 of 955 cells/µL (15%) with clinical stage III disease. During pre-ART counseling, the mother was educated on the signs and symptoms of BCG-IRIS and the importance of seeking follow-up care and remaining adherent to ART if symptoms arose. Three weeks after ART initiation, he was readmitted with intermittent subjective fevers, right axillary lymphadenopathy, and an ulcerated papule over the right deltoid region. He was subsequently discharged home with a diagnosis of local BCG-IRIS lymphadenitis. At six weeks post-ART initiation, he returned with suppurative lymphadenitis of the right axillary region that had completely eviscerated through the skin without signs of disseminated BCG disease. He was then started on an outpatient regimen of topical isoniazid, silver nitrate, and oral prednisolone. Throughout this time, the mother maintained good ART adherence despite this complication. After 2.5 months of ART and one month of specific treatment for the lymphadenitis, he had marked mass reduction, improved adenopathy, increased CD4 count, correction of anemia, and resolution of his acute malnutrition. He completely recovered and was symptom free two months after initial treatment without surgical intervention.

conclusionsThis case details the successful management of severe suppurative BCG-IRIS with a non-surgical approach and underlines the importance of pre-ART counseling on BCG-IRIS for caregivers, particularly for infants who initiate ART with advanced HIV.

Indexed as

BCG VaccineHIV InfectionsImmune Reconstitution Inflammatory SyndromeLymphadenitisHumansInfantMaleTreatment OutcomeBCG VaccineARTBCGHIVIRISLymphadenitis

Identifiers

PMID38678293
PMCPMC11056047
OpenAlexW4395703087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.